Laboratorio Reig Jofre SA Stock CINNOBER BOAT
Stocks
0RB1
ES0165359029
Pharmaceuticals
| Market Cap | 218M 0 248M 201M 188M 353M 23.44B 359M 2.41B 934M 11.55B 933M 912M 40.15B | P/E 2026 * |
13.4x | P/E 2027 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 303M 0 345M 279M 261M 489M 32.54B 498M 3.35B 1.3B 16.04B 1.29B 1.27B 55.74B | EV / Sales 2026 * |
0.83x | EV / Sales 2027 * | 0.76x |
| Free-Float |
19.75% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Laboratorio Reig Jofre SA
| 1 day | +2.41% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 2005-12-31 | |
Laura Martí
DFI | Director of Finance/CFO | - | 2023-12-19 |
Carmen Esclapés
CTO | Chief Tech/Sci/R&D Officer | - | 2002-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2014-12-30 | |
| Director/Board Member | 58 | 2014-12-30 | |
| Director/Board Member | - | 2017-11-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.41% | -.--% | - | - | 248M | |
| +0.93% | +2.65% | +42.33% | +145.77% | 1,006B | |
| +1.61% | +7.22% | +60.81% | +47.98% | 589B | |
| +3.51% | +12.31% | +31.15% | +78.88% | 430B | |
| -1.48% | +5.11% | +29.26% | +21.27% | 331B | |
| -0.87% | +5.26% | +37.32% | +23.36% | 288B | |
| -1.79% | +4.50% | +28.74% | +39.02% | 285B | |
| -2.44% | +4.86% | -28.72% | -42.85% | 213B | |
| +0.40% | +4.51% | +25.85% | +55.35% | 190B | |
| -1.05% | +0.06% | +16.91% | +59.86% | 154B | |
| Average | -0.35% | +5.96% | +27.07% | +47.63% | 387.31B | |
| Weighted average by Cap. | -0.32% | +5.38% | +34.95% | +70.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 365M 0 415M 336M 314M 590M 39.2B 600M 4.03B 1.56B 19.32B 1.56B 1.53B 67.15B | 392M 0 446M 361M 338M 633M 42.1B 645M 4.33B 1.68B 20.75B 1.68B 1.64B 72.12B |
| Net income | 16.7M 0 19.01M 15.39M 14.39M 26.98M 1.79B 27.48M 185M 71.51M 884M 71.4M 69.83M 3.07B | 9.5M 0 10.82M 8.75M 8.18M 15.35M 1.02B 15.63M 105M 40.68M 503M 40.61M 39.72M 1.75B |
| Net Debt | 84.7M 0 96.43M 78.04M 72.97M 137M 9.1B 139M 936M 363M 4.49B 362M 354M 15.59B | 78.7M 0 89.59M 72.51M 67.8M 127M 8.45B 129M 870M 337M 4.17B 336M 329M 14.48B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
